These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1979998)

  • 1. Amperozide, a putative anti-psychotic drug: uptake inhibition and release of dopamine in vitro in the rat brain.
    Eriksson E
    Life Sci; 1990; 47(23):2111-7. PubMed ID: 1979998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of amperozide on uptake and release of [3H]-dopamine in vitro from perfused rat striatal and limbic brain areas.
    Eriksson E; Christensson E
    Pharmacol Toxicol; 1990; 66 Suppl 1():45-8. PubMed ID: 2304895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens.
    Ichikawa J; Meltzer HY
    J Neurochem; 1992 Jun; 58(6):2285-91. PubMed ID: 1349347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of four novel diphenylbutylpiperazinepyridyl derivatives on release and inhibition of reuptake of dopamine, serotonin and noradrenaline by rat brain in vitro.
    Pettersson E
    Eur J Pharmacol; 1995 Aug; 282(1-3):131-5. PubMed ID: 7498267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GBR 12783, a potent and selective inhibitor of dopamine uptake: biochemical studies in vivo and ex vivo.
    Bonnet JJ; Costentin J
    Eur J Pharmacol; 1986 Feb; 121(2):199-209. PubMed ID: 3754516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible binding and recovery of the norepinephrine uptake system using an alkylating derivative of norepinephrine.
    Baker SP; Standifer KM; Kalberg CJ; Pitha J; Sumners C
    J Neurochem; 1988 Apr; 50(4):1044-52. PubMed ID: 2894406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the atypical antipsychotic drug, amperozide, on carrier-mediated striatal dopamine release measured in vivo.
    Yamamoto BK; Meltzer HY
    J Pharmacol Exp Ther; 1992 Oct; 263(1):180-5. PubMed ID: 1403783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of ibogaine on dopamine and serotonin transport in rat brain synaptosomes.
    Wells GB; Lopez MC; Tanaka JC
    Brain Res Bull; 1999 Apr; 48(6):641-7. PubMed ID: 10386845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic cocaine administration on [3H]dopamine uptake in the nucleus accumbens, striatum and frontal cortex of rats.
    Masserano JM; Venable D; Wyatt RJ
    J Pharmacol Exp Ther; 1994 Jul; 270(1):133-41. PubMed ID: 8035309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The atypical antipsychotic drug amperozide enhances rat cortical and striatal dopamine efflux.
    Pehek EA; Meltzer HY; Yamamoto BK
    Eur J Pharmacol; 1993 Aug; 240(1):107-9. PubMed ID: 8405119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
    Steele TD; Nichols DE; Yim GK
    Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of synaptosomal uptake of norepinephrine and dopamine by conformationally restricted sympathomimetic amines.
    Komiskey HL; Hsu FL; Bossart FJ; Fowble JW; Miller DD; Patil PN
    Eur J Pharmacol; 1978 Nov; 52(1):37-45. PubMed ID: 720387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of dopamine uptake and release in vitro in sheep and rat striatum.
    Jacocks HM; Izenwasser S; Werling LL; Cox BM
    Life Sci; 1991; 49(7):481-8. PubMed ID: 1830633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of amineptine with the neuronal dopamine uptake system: neurochemical in vitro and in vivo studies.
    Bonnet JJ; Chagraoui A; Protais P; Costentin J
    J Neural Transm; 1987; 69(3-4):211-20. PubMed ID: 3625193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
    Clarke PB; Reuben M
    Br J Pharmacol; 1996 Feb; 117(4):595-606. PubMed ID: 8646402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of amperozide on rat cortical 5-HT2 and striatal and limbic dopamine D2 receptor occupancy: implications for antipsychotic action.
    Meltzer HY; Zhang Y; Stockmeier CA
    Eur J Pharmacol; 1992 May; 216(1):67-71. PubMed ID: 1388121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of dopamine and noradrenaline transport in synaptosomes from cerebellum, striatum and frontal cortex of normal and reeler mice.
    Efthimiopoulos S; Giompres P; Valcana T
    J Neurosci Res; 1991 Aug; 29(4):510-9. PubMed ID: 1838778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mepiprazole, a new psychotropic drug: effects on uptake and retention of monoamines in rat brain synaptosomes.
    Placheta P; Singer E; Kriwanek W; Hertting G
    Psychopharmacology (Berl); 1976 Aug; 48(3):295-301. PubMed ID: 9660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The limbic functional selectivity of amperozide is not mediated by dopamine D2 receptors as assessed by in vitro and in vivo binding.
    Svartengren J; Celander M
    Eur J Pharmacol; 1994 Mar; 254(1-2):73-81. PubMed ID: 7911431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the presynaptic effects of quinine and quinidine on the release and uptake of monoamines in rat brain tissue.
    Clement EM; Grahame-Smith DG; Elliott JM
    Neuropharmacology; 1998 Jul; 37(7):945-51. PubMed ID: 9776390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.